Anthony J. Di Pasqua, PhD, President and CEO of DB Therapeutics, Inc.
Anthony J. Di Pasqua, PhD, has a doctorate in chemistry from Syracuse University, was a Ruth L. Kirschstein Postdoctoral Fellow in the Oncology Department at the Lombardi Comprehensive Cancer Center at Georgetown University, a postdoctoral research associate and then research assistant professor in the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill, an assistant professor of Pharmaceutical Sciences at the University of North Texas System College of Pharmacy, and is currently an assistant professor in Pharmaceutical Sciences at the Binghamton University School of Pharmacy and Pharmaceutical Sciences. In 2017, Dr. Di Pasqua and his frequent collaborator, Dr. Kenneth J. Balkus, Jr., with their business partner, Dr. Sanjay Thamake, started DB Therapeutics, Inc. DB Therapeutics, Inc. is developing a holmium-166-based radiotherapeutic bandages for skin cancer therapy.